Deutsche Märkte öffnen in 6 Stunden 24 Minuten
  • CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PR Newswire

    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees as equity inducement awards outside of the Company's Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Restated 2017 Equity Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved on May 12, 2021, in accordance with Nasdaq Listing Rule 5635(c)(4).

  • Dow Jones Futures: Market Rally At Key Level As Inflation Fears Intensify Sell-Off; Bitcoin Plunges On Tesla Move
    Investor's Business Daily

    Dow Jones Futures: Market Rally At Key Level As Inflation Fears Intensify Sell-Off; Bitcoin Plunges On Tesla Move

    The market rally is at a critical juncture as inflation fears intensify the sell-off. Bitcoin extended losses late on a Tesla move. Apple and Microsoft broke support.

  • FERRO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FOE and Encourages Investors to Contact the Firm
    GlobeNewswire

    FERRO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FOE and Encourages Investors to Contact the Firm

    NEW YORK, May 12, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Ferro Corporation (NYSE: FOE) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Prince International Corporation. Click here to learn more and participate in the action. On May 11, 2021, Ferro announced that it had signed an agreement to be acquired by Prince for approximately $2.1 billion. Pursuant to the merger agreement, Ferro stockholders will receive $22 in cash for each share of Ferro common stock owned. The deal is scheduled to close in the first quarter of 2022. Bragar Eagel & Squire is concerned that Ferro’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Ferro’s stockholders. If you own shares of Ferro and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at investigations@bespc.com or telephone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Melissa Fortunato, Esq.Alexandra Raymond, Esq.investigations@bespc.comwww.bespc.com